Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03757949 · ClinicalTrials.gov registry record · Phase 3
Nutrition Therapy in Improving Immune System in Patients With Bladder Cancer That Can Be Removed by Surgery
A Phase 3 study of Bladder Carcinoma, sponsored by SWOG Cancer Research Network.
- Active
- Registry status
- Phase 3
- Development phase
- 203
- Enrollment target
- 20
- Study locations
NCT03757949 is a Phase 3 study of Bladder Carcinoma that is active but no longer recruiting, run by SWOG Cancer Research Network. The registered enrollment target is 203 participants, below the 3,529-participant average among 10 other Bladder Carcinoma trials with a reported enrollment target (94% lower). The trial reports 20 study locations across 8 states.
The verdict
NCT03757949, a Phase 3 study of Bladder Carcinoma, is active but no longer recruiting, sponsored by SWOG Cancer Research Network.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 3
- Development phase
- 203 participants
- Enrollment target
- 20
- Study locations
Study Summary
This phase III trial studies how well nutrition therapy works in improving immune system in patients with bladder cancer that can be removed by surgery. Improving nutrition before and after surgery may reduce the infections and other problems that sometimes occur after surgery.
Conditions Studied
Interventions
- OTHER Quality-of-Life Assessment
- OTHER Laboratory Biomarker Analysis
- OTHER Questionnaire Administration
- DIETARY_SUPPLEMENT Nutritional Intervention
- OTHER Placebo Administration
Study Locations (20)
California
- City of Hope Comprehensive Cancer Center - Duarte
- Los Angeles County-USC Medical Center - Los Angeles
- USC / Norris Comprehensive Cancer Center - Los Angeles
- USC Norris Oncology/Hematology-Newport Beach - Newport Beach
- Keck Medical Center of USC Pasadena - Pasadena
Kansas
- University of Kansas Clinical Research Center - Fairway
- University of Kansas Cancer Center - Kansas City
- University of Kansas Hospital-Indian Creek Campus - Overland Park
- University of Kansas Hospital-Westwood Cancer Center - Westwood
Illinois
- Northwestern University - Chicago
- Cancer Care Specialists of Illinois - Decatur - Decatur
- Decatur Memorial Hospital - Decatur
Michigan
- Saint Joseph Mercy Hospital - Ann Arbor
- IHA Hematology Oncology Consultants-Brighton - Brighton
- Saint Joseph Mercy Brighton - Brighton
Maine
- Maine Medical Center-Bramhall Campus - Portland
- Maine Medical Center- Scarborough Campus - Scarborough
Colorado
- University of Colorado Hospital - Aurora
Florida
- Mayo Clinic in Florida - Jacksonville
Louisiana
- LSU Healthcare Network / Metairie Multi-Specialty Clinic - Metairie
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 203 participants |
| Start Date | 2019-03-05 |
| Est. Completion | 2027-01-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03757949
The ClinicalTrials.gov registry entry for NCT03757949 describes a study currently listed as active not recruiting, categorized as Phase 3. The registered enrollment target is 203 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,529-participant average among 10 other Bladder Carcinoma trials with a reported enrollment target (94% lower). The listed sponsor is SWOG Cancer Research Network, which has 270 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Bladder Carcinoma appearing as the primary indexed condition, and to 5 interventions - of which Quality-of-Life Assessment is the first listed.
NCT03757949 reports 20 study locations spanning 8 distinct geographic areas - top geographies include California, Kansas, Illinois.
Frequently Asked Questions
What is clinical trial NCT03757949 about?
NCT03757949 is a clinical study titled "Nutrition Therapy in Improving Immune System in Patients With Bladder Cancer That Can Be Removed by Surgery". This phase III trial studies how well nutrition therapy works in improving immune system in patients with bladder cancer that can be removed by surgery. Improving nutrition before and after surgery may reduce the infections and other problems that sometimes occur after surgery.
What is the current status of trial NCT03757949?
This trial is currently active not recruiting. It is a Phase 3 study. The enrollment target is 203 participants. The study started on 2019-03-05. Estimated completion is 2027-01-01.
What conditions does trial NCT03757949 study?
This clinical trial studies the following conditions: Bladder Carcinoma.
What interventions are being tested in trial NCT03757949?
The interventions under investigation include: Quality-of-Life Assessment (OTHER), Laboratory Biomarker Analysis (OTHER), Questionnaire Administration (OTHER), Nutritional Intervention (DIETARY_SUPPLEMENT), Placebo Administration (OTHER).
Who is sponsoring clinical trial NCT03757949?
This trial is sponsored by SWOG Cancer Research Network, which has 270 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03757949 being conducted?
This trial has 20 study locations across California, Colorado, Florida, Illinois, Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bladder Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
RECRUITING · Phase 1
-
Exploration of HRQOL and Urinary Outcomes Following Partial Cystectomy
RECRUITING
-
Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers
RECRUITING · NA
-
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
RECRUITING
-
Bladder Bank (a Prospective Banking Study)
RECRUITING
-
The Vanguard Study: Testing a New Way to Screen for Cancer
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.